Top Markets
Coin of the day
MultiCell Technologies, Inc. MultiCell Technologies, Inc.

MultiCell Technologies, Inc.

MCET
Rang in aandelen #20716
MultiCell Technologies, Inc., a biopharmaceutical company, develops novel... MultiCell Technologies, Inc., a biopharmaceutical company, develops novel therapeutics and discovery tools for the treatment of neurological disorders, hepatic disease, cancer, and interventional cardiology and peripheral vessel applications. Its product portfolio comprises MCT-125, a Phase II therapeutic candidate for the treatment of primary multiple sclerosis-related fatigue; MCT-465, a preclinical synthetic double-stranded RNA (dsRNA) therapeutic candidate and potent immune enhancer for the treatment of solid tumor cancers; and MCT-485, a discovery stage dsRNA therapeutic candidate with tumor cytolytic properties for the treatment of various cancers. The company also develops Ideal BioStent, a bioabsorbable stent for interventional cardiology and peripheral vessel applications. MultiCell Technologies, Inc. has a license agreement with Corning Incorporated and Pfizer Inc. The company was formerly known as Exten Industries, Inc. and changed its name to MultiCell Technologies, Inc. in April 2004. MultiCell Technologies, Inc. was founded in 1962 and is headquartered in Woonsocket, Rhode Island.
Aandeelprijs
$0.00001
Marktkapitalisatie
$50.01K
Verandering (1 dag)
0.00%
Verandering (1 jaar)
0.00%
Land
US
Handel MultiCell Technologies, Inc. (MCET)

Categorie

Aandelsplitsingen voor MultiCell Technologies, Inc. (MCET)
Het aandeel MultiCell Technologies, Inc. (symbool: MCET) heeft in totaal 3 splitsingen ondergaan.
De meest recente splitsing vond plaats op May 20, 2005.
Eén aandeel MCET dat vóór Nov 23, 1992 werd gekocht, staat nu gelijk aan 0.0212 aandelen MCET.
Lijst van aandelen splitsingen
Jaar Splitsing Vermenigvuldiging Cumulatieve vermenigvuldiging
2005-05-20 1:5 x0.2 x0.0212
1992-12-01 1:10 x0.1 x0.106
1992-11-23 53:50 x1.06 x1.06
Aandelsplitsingen van vergelijkbare bedrijven of concurrenten
Bedrijf Aantal aandelen splitsingen Cumulatieve vermenigvuldiging Land
5 x199
DK
1 x2
US
0 -
US
0 -
BE
1 x3
AU